Akash Bhaduri
About Akash Bhaduri
Akash Bhaduri is a Senior Analyst at The Smart Cube, specializing in cost modeling and structuring in the healthcare and life sciences sectors. He has a background in pharmacy and pharmaceutical management, with experience in database analysis and client solutions.
Current Role at The Smart Cube
Akash Bhaduri currently serves as a Senior Analyst at The Smart Cube, a position he has held since 2023. He works in a hybrid capacity from Noida, Uttar Pradesh, India. In this role, he focuses on transforming database analyses into actionable solutions for clients, leveraging his expertise in cost modeling and structuring within the healthcare and life sciences sectors.
Previous Experience at The Smart Cube
Before his current role, Akash worked as an Analyst at The Smart Cube from 2022 to 2023 for one year. During this time, he contributed to various projects, utilizing his analytical skills to support client needs and enhance operational efficiencies.
Professional Background in Pharmaceuticals
Akash has a diverse background in the pharmaceutical industry. He worked as a Manufacturing Chemist at Strassenburg Pharmaceuticals Limited for five months in 2018. Additionally, he served as a Project Trainee at Alembic Pharmaceuticals Limited for two months in 2021. His experience includes assisting a global medical device company in implementing electronic Instructions for Use (eIFU) by identifying an optimal supplier.
Educational Qualifications
Akash Bhaduri holds an MBA in Pharmaceutical Management from SVKM's Narsee Monjee Institute of Management Studies (NMIMS), which he completed from 2020 to 2022. He also earned a Bachelor of Pharmacy (BPharm) from West Bengal University of Technology, Kolkata, from 2014 to 2018. Earlier, he studied Biology/Biological Sciences at The Modern Academy, achieving ISC from 2012 to 2014.
Specialization in Healthcare and Life Sciences
Akash specializes in cost modeling and structuring within the healthcare and life sciences sectors. He has played a key role in helping clients invest in new Stock Keeping Units (SKUs) within the life sciences domain, demonstrating his ability to apply analytical insights to drive business decisions.